Assignee
CIPLA LTD
IN·122 granted patents·103 pending applications·386 citations·filing 2001–2024
Top patents by PatentIndex Score
225 records- 0195US9901585B2Combination of azelastine and fluticasone for nasal administrationCIPLA LTD·Filed 2016·Granted Feb 27, 2018·12 cites·30 claims
- 0292US9913853B2Stabilized liquid fosaprepitant formulationsCIPLA LTD·Filed 2016·Granted Mar 13, 2018·7 cites·22 claims
- 0392USD590495SMultidose inhalerCIPLA LTD·Filed 2007·Granted Apr 14, 2009·48 cites·1 claims
- 0490US10098890B2Stable carfilzomib formulationsCIPLA LTD·Filed 2017·Granted Oct 16, 2018·7 cites·21 claims
- 0590US9227990B2Antiviral phosphonate analogues and process for preparation thereofCIPLA LTD·Filed 2013·Granted Jan 5, 2016·14 cites·16 claims
- 0690US7638627B2Process of preparing imatinib and imatinib prepared therebyCIPLA LTD·Filed 2004·Granted Dec 29, 2009·22 cites·32 claims
- 0790USD590938SMultidose inhalerCIPLA LTD·Filed 2008·Granted Apr 21, 2009·43 cites·1 claims
- 0889US10301282B2Polymorphic form X of nilotinib dihydrochloride hydrateCIPLA LTD·Filed 2016·Granted May 28, 2019·6 cites·15 claims
- 0987US11077124B2Pharmaceutical compositionsCIPLA LTD·Filed 2017·Granted Aug 3, 2021·2 cites·22 claims
- 1087US10912734B2Depot formulationCIPLA LTD·Filed 2019·Granted Feb 9, 2021·2 cites·17 claims
- 1186US10940274B2Nasal spray assemblyCIPLA LTD·Filed 2016·Granted Mar 9, 2021·9 cites·18 claims
- 1286US10328153B2Rifaximin complexesCIPLA LTD·Filed 2018·Granted Jun 25, 2019·3 cites·20 claims
- 1385US10307432B2Stabilized liquid fosaprepitant formulationsCIPLA LTD·Filed 2018·Granted Jun 4, 2019·2 cites·21 claims
- 1484US6995286B2Process for preparing isomers of salbutamolCIPLA LTD·Filed 2001·Granted Feb 7, 2006·11 cites·8 claims
- 1583US12109200B2RifaximinCIPLA LTD·Filed 2022·Granted Oct 8, 2024·0 cites·4 claims
- 1683US12109270B2Rifaximin complexesCIPLA LTD·Filed 2022·Granted Oct 8, 2024·0 cites·12 claims
- 1783US9259428B2Combination of azelastine and fluticasone for nasal administrationCIPLA LTD·Filed 2015·Granted Feb 16, 2016·2 cites·30 claims
- 1882US11234981B2Combination therapy for use in treating retroviral infectionsCIPLA LTD·Filed 2018·Granted Feb 1, 2022·1 cites·23 claims
- 1982US9993561B2Rifaximin complexesCIPLA LTD·Filed 2014·Granted Jun 12, 2018·3 cites·22 claims
- 2082US9993560B2Rifaximin complexesCIPLA LTD·Filed 2014·Granted Jun 12, 2018·3 cites·26 claims
- 2181US10709715B2Method of treating hypertensionCIPLA LTD·Filed 2018·Granted Jul 14, 2020·1 cites·21 claims
- 2280US10391080B2Ketorolac for the treatment of cancerCIPLA LTD·Filed 2017·Granted Aug 27, 2019·1 cites·15 claims
- 2380US10149848B2Method for the treatment of bladder cancerCIPLA LTD·Filed 2016·Granted Dec 11, 2018·1 cites·12 claims
- 2480US9867865B1Mesalamine for the treatment of cancerCIPLA LTD·Filed 2017·Granted Jan 16, 2018·1 cites·17 claims
- 2580US9763901B2Treatment of hepatitis C using histone deacetylase inhibitorsCIPLA LTD·Filed 2016·Granted Sep 19, 2017·1 cites·6 claims
- 2680US8937057B2Combination of azelastine and mometasone for nasal administrationCIPLA LTD·Filed 2012·Granted Jan 20, 2015·2 cites·30 claims
- 2780US8933060B2Combination of azelastine and ciclesonide for nasal administrationCIPLA LTD·Filed 2012·Granted Jan 13, 2015·2 cites·26 claims
- 2879US10966982B2Stable pharmaceutical formulations of pemetrexedCIPLA LTD·Filed 2019·Granted Apr 6, 2021·2 cites·24 claims
- 2979US7989636B2Process for the preparation of pure anastrozoleCIPLA LTD·Filed 2007·Granted Aug 2, 2011·2 cites·29 claims
- 3079US7285669B2Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazoleCIPLA LTD·Filed 2003·Granted Oct 23, 2007·8 cites·18 claims
- 3178US2024285629A1Combination Therapy for Use in Treating Retroviral InfectionsCIPLA LTD·Filed 2024·Application pending·0 cites
- 3277US7973173B2Process for the synthesis of an ACE inhibitorCIPLA LTD·Filed 2006·Granted Jul 5, 2011·3 cites·14 claims
- 3377US2024016814A1Method of treating hypertensionCIPLA LTD·Filed 2023·Application pending·0 cites
- 3476US9446054B2Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroidsCIPLA LTD·Filed 2014·Granted Sep 20, 2016·2 cites·10 claims
- 3576US7892483B2Sterilization processCIPLA LTD·Filed 2005·Granted Feb 22, 2011·3 cites·22 claims
- 3675US12472190B2Pharmaceutical compositionsCIPLA LTD·Filed 2021·Granted Nov 18, 2025·0 cites·19 claims
- 3775US2020147225A1Rifaximin complexesCIPLA LTD·Filed 2019·Application pending·0 cites
- 3874US7666896B2Process for the preparation of perindoprilCIPLA LTD·Filed 2005·Granted Feb 23, 2010·1 cites·19 claims
- 3974US7470789B2Fexofenadine polymorphs and processes of preparing the sameCIPLA LTD·Filed 2004·Granted Dec 30, 2008·6 cites·16 claims
- 4073US11129836B2PAR-4 agonists for the treatment of cancerCIPLA LTD·Filed 2019·Granted Sep 28, 2021·0 cites·8 claims
- 4173US8006695B2InhalerCIPLA LTD·Filed 2005·Granted Aug 30, 2011·12 cites·41 claims
- 4273US7112577B2Pharmaceutically acceptable alendronate salts in amorphous formCIPLA LTD·Filed 2002·Granted Sep 26, 2006·6 cites·14 claims
- 4372US12090163B2Pharmaceutical compositionsCIPLA LTD·Filed 2018·Granted Sep 17, 2024·1 cites·20 claims
- 4472US7579505B2Crystalline levosalbutamol sulphate and polymorphic forms thereofCIPLA LTD·Filed 2005·Granted Aug 25, 2009·2 cites·12 claims
- 4571US7538249B2Tolterodine, compositions and uses thereof, and preparation of the sameCIPLA LTD·Filed 2004·Granted May 26, 2009·4 cites·24 claims
- 4670US8003804B2Synthesis of 4-[1-(4-cyano phenyl)-(1,2,4-triazol-1-yl)methyl] benzonitrile and 4-[1-(1H-1,2,4-triazol-1-yl)methylene benzonitrile intermediateCIPLA LTD·Filed 2007·Granted Aug 23, 2011·1 cites·3 claims
- 4770US7550593B2Process for the preparation of finasteride Form ICIPLA LTD·Filed 2004·Granted Jun 23, 2009·1 cites·8 claims
- 4870US2021401851A1Par-4 agonists for the treatment of cancerCIPLA LTD·Filed 2021·Application pending·0 cites
- 4970US2023030113A1Method of treating hypertensionCIPLA LTD·Filed 2022·Application pending·0 cites
- 5070US2023119206A1Compositions comprising ibrutinib and an alkaloid having enhanced bioavailabilityCIPLA LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 225 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CIPLA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →